Taconic Capital Advisors LP Innoviva, Inc. Transaction History

Taconic Capital Advisors LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$10.05 - $14.55 $1.11 Million - $1.6 Million	-110,000 Reduced 42.31%	150,000 $1.58 Million
Q2 2019 Aug 14, 2019	SELL	$13.1 - $14.95 $327,500 - $373,750	-25,000 Reduced 8.77%	260,000 $3.79 Million
Q1 2019 May 15, 2019	BUY	$13.69 - $20.06 $1.16 Million - $1.71 Million	85,000 Added 42.5%	285,000 $4 Million
Q4 2018 Feb 14, 2019	BUY	$13.96 - $18.26 $349,000 - $456,500	25,000 Added 14.29%	200,000 $3.49 Million
Q3 2018 Nov 14, 2018	BUY	$13.63 - $15.7 $340,750 - $392,500	25,000 Added 16.67%	175,000 $2.67 Million
Q4 2017 Feb 14, 2018	BUY	$11.73 - $14.75 $1.76 Million - $2.21 Million	150,000	150,000 $2.13 Million

243

77.7M

52.8K

800

Ticker INVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 69,706,000
Market Cap $1.2B
Description
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...

Get notified when there are updates to the investment portfolio of Taconic Capital Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Taconic Capital Advisors LP with notifications on news.